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Abstract. Mechanisms of synergistic effect of thermotherapy 
and chemotherapy on human lung adenocarcinoma cell 
growth are unclear. The purpose of this study was to inves-
tigate these effects and explore the function of ROS, Akt and 
caspase-3 in relation to these. A549 cells were subjected to 
different thermochemotherapy treatments: 43˚C heat + 50 µg/l 
paclitaxel (thermochemotherapy group), 43˚C heat + 50 µg/l 
paclitaxel + 1 µmol/l wortmannin (wortmannin group), 43˚C 
heat + 50 µg/l paclitaxel + 30 µmol/l NAC (NAC group) and 
50 µg/l paclitaxel (chemotherapy group). The cells without 
any treatment were regarded as controls. Cell proliferation 
rates were measured with MTT assay and intracellular ROS 
levels were detected with fluorescence labeling technologies. 
Phosphorylation of Akt and caspase-3 expression were deter-
mined by western blotting and the cell apoptosis rates were 
examined by flow cytometry. Tests in vivo were carried out 
at the same time. It was found that the cell proliferation rates 
of the thermochemotherapy group were significantly lower 
compared to those of the controls or the chemotherapy group 
(P<0.05). The intracellular ROS levels of the thermochemo-
therapy group were elevated significantly compared with 
those of other groups, and these changes could be reversed 
using the ROS inhibitor NAC but not a PI3K inhibitor (wort-
mannin). Phosphorylation of Akt was significantly decreased 
in the thermochemotherapy group (P<0.05), which could be 
blocked by wortmannin, but increased by NAC (P<0.05). The 
caspase-3 expression levels and cell apoptosis rates of the 
thermochemotherapy group were higher compared to those 
of the other groups (P<0.05). All results have been confirmed 
by in vivo tests. Thus, the combination of thermotherapy with 
chemotherapy showed a stronger inhibitory effect on A549 
cell growth compared to chemotherapy alone, which may be 
able to cause additional cell apoptosis through inhibition of 
Akt phosphorylation and activation of caspases by increased 
intracellular ROS production.
Introduction
Lung cancer is one of the most common malignant tumors 
worldwide and non-small cell lung cancer accounts for 80% 
of all lung cancer cases. Thermotherapy is an approach 
taking advantage of biological effects of heat to cure tumors. 
Thermotherapy undergoes a systematic research with the 
medicine development and equipment advancement (1). Now, 
thermotherapy is regarded as an effective treatment such as 
surgery, radiotherapy, chemotherapy and biological treatment 
(2). In recent years, tumor thermotherapy has been widely 
used to treat cancer (3), including lung cancer (4). Tumor 
thermotherapy increased tumor cell sensitivity to drugs in 
the effective temperature range, reversed tumor cell drug-
resistance and induce apoptosis (5).
Intracellular ROS could be induced and affected by many 
factors such as heat, cell cytokines or some chemicals. Its 
function is to signal to activate cellular apoptosis inducing cell 
apoptosis pathway (6-9). However, UV radiation was found to 
be able to lead to increased production of ROS and activation 
of mitogen activated protein kinase (MAPK) pathway (10). 
As a member of MAPK family, protein kinase B (PKB)/Akt 
plays key roles on regulation of cell growth and apoptosis. 
Phosphorylated Akt (p-Akt) takes part in many physiological 
and pathological processes directly or indirectly. Activation 
of Akt pathway showed an obvious promotion on cell growth 
and was necessary to normal cell growth (11,12). In addition, 
activated Akt (13), but inactivated cysteinyl aspartate-specific 
proteinases (caspase) simultaneously were observed in most 
tumor cells, which might be responsible for tumor occur-
rence and development (14). Caspase is the core regulatory 
element in the formation of cell apoptosis regulating network 
and could be activated by self-catalysis or caspase cascade 
catalysis. Oxidative stress was able to induce elevated 
caspase-3 activation and increased cell apoptosis (15) through 
degradating more target proteins (16).
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We observed that thermotherapy in combination with 
chemotherapy showed stronger inhibitory effect on lung 
tumor cell growth than thermotherapy or chemotherapy alone 
(17), the molecular mechanisms in the process remained 
unclear.
Materials and methods
Cell culture and cell treatments. Human lung adenocarcinoma 
A549 cell line was purchased from Shanghai Cell Biology 
Institute Cell Bank, (China) and was cultured in F-12k cell 
supernatant (Sigma, St. Louis, MO, USA) supplemented with 
10% fetal calf serum (Sigma) at 37˚C in a 5% CO2 saturated 
humidity atmosphere. Logarithmic phase cells were digested 
with 5% trypsin solution and the digestion was inactivated in 
cell supernatant, and then was separated into single cells. The 
cell density was diluted into 2.5x107 cells/l and 6 ml of the cell 
suspension was added into each well of culture plates. Then 
cells were cultured at 37˚C in a 5% CO2 humidified incubator 
(Heraeus, Germany). After culturing for 24 h, the cells were 
subjected to different group schemes as follows: cells treated 
only by 50 µg/l paclitaxel (Taiji Group Sichuan Taiji Pharmacy 
Co., Ltd., China; the approval number: GY H19994040) were 
the chemotherapy group while cells treated with 50 µg/l pacli-
taxel and 43˚C heat were the thermo-chemotherapy group. Cells 
in wortmannin (Alexis, USA) group were treated by thermo-
chemotherapy combined with 1 µmol/l wortmannin and cells 
in NAC (Sigma) group were treated by thermo-chemotherapy 
combined with 30 µmol/l NAC. The cells without any treat-
ment were regarded as controls. Hyperthermic treatments 
were performed by immersing either the culture flasks or 
parafilm-wrapped 96-well plates in a waterbath at 43˚C for 
90 min.
MTT assay. Single cell suspension was prepared with the cells 
in logarithmic phase and cell density was adjusted to 2.5x107 
cells/l. Then this cell suspension was seeded into 96-well 
plates, 200 µl per well, and cultured at 37˚C in a 5% CO2 
humidified incubator. After 24 h, cells were treated according 
to different schemes described above (6-wells were assayed 
for each group and repeated three times). The treated cells 
were incubated for 4 h and 20 µl of the solution containing 
5 g/l MTT (Sigma) was added to each well and incubation for 
another 4 h was performed. MTT was discarded and 150 µl 
dimethylsulfoxide (DMSO) (Takara, China) was added to 
each well, and then vortexed for 10 min to dissolve the crystal. 
DMSO was used as negative control. Absorbance (A) value 
was measured at 492 nm with the microplate reader (Sunrise 
China). Cell proliferation rates were calculated according to 
the following formula: cell proliferation rate (%) = (average A 
value of experimental group/average A value of control group) 
x 100%.
Intracellular ROS detection. After the treatment was 
performed, about 1x106 cells in the logarithmic growth phase 
were collected, washed by PBS and centrifuged at 1200 r/
min for 5 min. Then reagent was added and cultured at 37˚C 
for 20 min. Intracellular ROS was detected using Reactive 
Oxygen Species Testing kit (Shanghai Jiemei Gene Medicine 
Technology Co., Ltd., China). Preservative medium was 
added and detected at 490 nm (excitation) and 530 nm (emis-
sion) qualitatively by fluorescence microscope (Olympus, 
Japan) and quantitatively by F-4500 fluorospectrophotometer 
(Hitachi, Japan).
Western blotting. Cells in logarithmic phase (1x106) (in vitro) 
or 50 mg tissue (in vivo) from each group were harvested and 
suspended in cell lysis buffer containing 30 mmol/l NaHCO3, 
0.1 mmol/l EDTA, 0.1 mmol/l DTT, 0.5 mmol/l PMSF and 
2 mg/l aprotinin. Cells were lysed on ice and centrifuged at 
10,000 r/min and 4˚C for 10 min. The supernatant and loading 
buffer was mixed. Equal amount of total protein dissolved 
in the mixture of each sample was loaded and seperated by 
sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) (Bio-Rad Laboratories, Hercules, CA, USA) and 
transferred onto nitrocellulose membrane (Beijing Applygen 
Technology Ltd., Beijing, China) for antibody blotting. The 
membrane was incubated with a rabbit monoclonal antibody 
against Akt (Cell Signaling Technology, Inc., Danvers, MA), 
a rabbit monoclonal antibody against p-Akt (Ser473) (587F11) 
(Cell Signaling Technology, Inc.), a rabbit monoclonal anti-
body against caspase-3 (Cell Signaling Technology, Inc.) or 
a rabbit monoclonal antibody against β-actin (Cell Signaling 
Technology, Inc.) overnight at 4˚C, respectively. After being 
incubated with goat anti-rabbit IgG antibodies (1:300 dilu-
tion) (Beijing Zhongshan Jinqiao Biology Technology Co., 
Ltd., Beijing, China) for 2 h. The membrane was subjected to 
immunoblot analysis and the enhanced chemiluminescence 
method (ECL kit, China) and HRP-DAB kit (Tiangen, Biotech 
Co., Ltd., Beijing, China) were used to visualize the proteins. 
β-actin was used as an internal control. Gel imaging system 
(Gene Genius, USA) was used to capture images. Semi-
quantitative values of p-Akt and caspase-3 were measured by 
the ratio of the bands of t-Akt and β-actin.
Cell apoptosis detection. After cell concentration was 
adjusted, cells were seeded into 50-ml dishes to culture, 
and then they were treated according to schemes mentioned 
in cell culture and cell treatments. Cells in each group were 
suspended as single cells. A total of 1x106 cells were collected 
to tubes, and fixed in ice-cold 70% ethanol for 12 h at 4˚C. The 
ethanol was discarded and cells were digested by 1 ml 0.5% 
typsin (pH 1.5-2.0) for 10 min and washed with PBS, labeled 
with propidum iodide (PI) and filtered by 500-mesh screen to 
obtain single cell suspension and analyzed directly by FACS 
420 flow cytometry (B&D Systems, USA).
Graft inhibition rates in nude mice. Thirty BALB/c-nu/nu nude 
mice (purchased from Shanghai Slack Experimental Animals 
Co., Ltd., China) were treated according to the following 
schemes: chemotherapy group (50 µg/kg paclitaxel intra-
peritoneal injection), thermo-chemotherapy group (50 µg/
kg paclitaxel intraperitoneal injection with 43˚C waterbath), 
wortmannin group (thermo-chemotherapy combined with 
wortmannin intraperitoneal injection), NAC group (thermo-
chemotherapy combined with NAC intraperitoneal injection) 
and controls (equal saline intraperitoneal injection without 
any other treatments). There were 6 nude mice in each group 
and every nude mouse was treated once a week for 3 weeks. 
Nude mice were sacrificed 2 days after the last treatment. 
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Changes in behavior, eating, defecation and weight were 
tracked. When grafts were removed, graft inhibition rates 
were calculated according to the following formula: graft 
inhibition rates (%) = (graft quality in control group - graft 
quality in experimental group)/graft quality in control group 
x 100%. The institutional committee for animal research 
approved these experiments.
Statistical analysis. The software of SPSS 13.0 was employed 
for data analysis and results are shown as mean ± SD. 
Comparisons among groups were analyzed with a one-way 
ANOVA and LSD method was applied for multiple compari-
sons. P<0.05 was regarded as significant.
Results
Cell proliferation rates. A549 cells in control group grew 
normally in fusiform or polygonal shape. In chemotherapy 
group, the number of A549 cells became less and many 
cells were detached from the flask wall. Many cells were in 
division phase and cell bodies became round and small. In 
thermo-chemotherapy group, cell morphology was in the 
shape described as in chemotherapy group, but more cells 
died. After wortmannin was added, the number of cells 
became less but most cells were alive after NAC was added 
(Fig. 1).
Compared with control group (100.00±0.00%), signifi-
cantly decreased proliferation rate was detected in the groups 
treated with chemotherapy (78.77±2.38%) and thermo-
chemotherapy (56.34±4.30%) (P<0.05) and proliferation rate 
in thermo-chemotherapy group was significantly lower than 
in other groups (P<0.05). Proliferation rate in wortmannin 
group (47.40±0.01%) was significantly lower than that in 
thermo-chemotherapy group (P<0.05) and there was no 
significant difference between NAC group (92.65±0.09%) 
and control group (P>0.05), which indicated that thermo-
therapy in combination with chemotherapy could inhibit 
A549 cells growth distinctly and ROS and Akt pathways 
played a role inhibited by their own inhibitors (Fig. 2).
Changes of intracellular ROS. Cells in control group were 
red, which showed there was no ROS in them (Fig. 3A); 
cells in chemotherapy group were green, which indicated 
ROS in them (Fig. 3B); cells in thermo-chemotherapy 
group were bright green showing increased ROS (Fig. 3C). 
Wortmannin had no effect on ROS produced by thermo-
chemotherapy (Fig. 3D), but after NAC was added, cells 
became red (Fig. 3E).
Figure 1. A549 cells in each group. A549 cells were observed by a micro-
scope and at magnification x100. (A) A549 cells in control group were in 
fusiform or polygonal shape. (B) A549 cells in chemotherapy group became 
less and many cells detached from the flask wall. (C) A549 cells in thermo-
chemotherapy group were similar to those in chemotherapy group, but more 
cells died. (D) Increased cell death was seen in A549 cells in wortmannin 
group. (E) A549 cells in NAC group were alive as in control.
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Figure 2. Proliferation rates, apoptosis rates and graft inhibition rates. Proliferation rates were measured by MTT and it decreased significantly in 
thermo-chemotherapy group compared with control and chemotherapy group. Proliferation rate in wortmannin group was significantly lower than that in 
thermo-chemotherapy group and there was no significant difference between NAC group and control group. Apoptosis rates were analyzed by FCM and the 
highest rate was in wortmannin group and that in thermo-chemotherapy group was higher than that in control and chemotherapy group. Graft inhibition rate 
was higher in thermo-chemotherapy group than in control and chemotherapy group. There was no significance difference between control group and NAC 
group. *P<0.05 vs. control group, #P<0.05 vs. thermo-chemotherapy group. Thermotherapy in combination with chemotherapy could inhibit A549 cell growth 
by leading to apoptosis and ROS and Akt pathway played a role, which was confirmed in vivo. Each column represents mean ± SD value for three repeated 
independent experiments.
Figure 3. Changes of intracellular ROS. Intracellular ROS changes were detected qualitatively and quantitatively, respectively, by fluorescence microscope 
and F-4500 fluorospectrophotometer. (A) Cells in control group were red. (B) Cells in chemotherapy group were green. (C) Cells in thermo-chemotherapy 
group were bright green. (D) Wortmannin had no effect on ROS and (E) NAC inhibits ROS thoroughly to make cells red. (F) ROS production was the highest 
in thermo-chemotherapy group and NAC decreased its production significantly. Wortmannin has no effect on ROS production. Each column represents 
mean ± SD value for three repeated independent experiments. *P<0.05 vs. control group; #P<0.05 vs. thermo-chemotherapy group.
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Compa red  with  t her mo - chemot herapy g roup 
(139.93±37.59%), significantly decreased ROS production was 
detected in control group (58.07±2%), chemotherapy group 
(74.40±3.01%) and NAC group (52.11±1.05%) (P<0.05) and 
wortmannin had no effect on ROS (126.48±8.76%) (P>0.05), 
indicating that thermo-chemotherapy induced production of 
ROS and ROS was upstream of the Akt pathway (Fig. 3F).
Effect of thermo-chemotherapy on phosphorylation of Akt 
and caspase-3 expression. Compared with thermo-chemo-
therapy group (0.63±0.00%), Akt phosphorylation in control 
group (1.62±0.03%) and chemotherapy group (1.01±0.41%) 
decreased significantly (P<0.05) and wortmanin completely 
inhibited Akt phosphorylation (0.00±0.00%) (P<0.05); but 
when NAC, the specific inhibitor of ROS, was added, Akt 
phosphorylation (1.08±0.24%) was significantly higher than 
that in thermo-chemotherapy group (P<0.05) (Fig. 4A and C).
Caspase-3 expression in thermo-chemotherapy group 
(1.02±0.02%) was significantly higher than that in control 
group (0.48±0.11%) and chemotherapy group (0.67±0.02%) 
(P<0.05); after Akt specific inhibitor wortmannin pretreat-
ment, caspase-3 expression (1.05±0.09%) was significantly 
higher than that in thermo-chemotherapy group (P<0.05); NAC 
could inhibited caspase-3 expression completely (0.00±0.00%) 
(P<0.05) (Fig. 4B and C) showing that ROS could inhibit 
activation of Akt pathway and activate the caspase pathway. 
The Akt pathway was upstream of caspase pathway in thermo-
chemotherapy.
Cell apoptosis. Cell apoptosis rate in control group was 
(1.22±0.18%) and significantly increased cell apoptosis rates 
were observed in chemotherapy group (17.70±3.23%)  and 
thermo-chemotherapy group (30.39±2.89%) (P<0.05). Cell 
apoptosis rate in thermo-chemotherapy group was signifi-
cantly higher than that in chemotherapy group (P<0.05). 
Compared with thermo-chemotherapy group, cell apop-
tosis rate in wortmannin group (43.23±9.26%) increased 
significantly and decreased significantly in NAC group 
(2.80±0.99%) (P<0.05) (Fig. 2). Thermotherapy in combi-
nation with chemotherapy inhibited A549 cell growth by 
leading to apoptosis through induction of ROS production 
and subsequent inhibition of Akt phosphorylation and activa-
tion of caspase.
Results of tests in vivo. A549 cells were injected subcutaneously 
into nude mice and grafts occurred about 1 week later, with 
round or oval shape. Compared with thermo-chemotherapy 
group (46.34±1.03%), graft inhibition rate in wortmannin 
group (48.97±0.11%) increased significantly, and decreased 
significantly in the control group (0.00±0.00%), chemotherapy 
group (38.76±1.83%) and NAC group (0.05±0.01%) (P<0.05), 
but there was no significant difference between control group 
and NAC groups (P>0.05) (Fig. 2).
Akt phosphorylation in thermo-chemotherapy group 
(0.66±0.06%) decreased significantly when compared with 
control group (1.66±0.06%) (P<0.05) and increased signifi-
cantly in chemotherapy group (1.06±0.04%) and NAC group 
(1.07±0.02%) when compared with thermo-chemotherapy 
group (P<0.05), but was inhibited completely in wortmannin 
group (0.00±0.00%) (P<0.05) (Fig. 5A and C).
Caspase-3 expression in thermo-chemotherapy group 
(1.01±0.01%) was significantly higher than that in control 
group (0.49±0.10%) and in chemotherapy group (0.66±0.03%) 
(P<0.05); Caspase-3 expression in wortmannin group 
(1.06±0.07%) increased significantly (P<0.05) and caspase-3 
expression in NAC group (0.00±0.00%) was inhibited 
completely (P<0.05) (Fig. 5B and C). All these results in cells 
were authenticated in vivo.
Discussion
Thermotherapy is a new treatment of tumors, which plays 
an important role in comprehensive treatment of tumors. 
Thermotherapy in combination with chemotherapy is able 
to improve tumor treatment efficiency (18). Initially thermo-
Figure 4. Phosphorylation of Akt and caspase-3 expression in cells. (A) 
Compared with control group and chemotherapy group, phosphoryla-
tion of Akt decreased significantly in thermo-chemotherapy group. NAC 
increased and wortmannin inhibited it thoroughly. (B) Caspase-3 expression 
increased in thermo-chemotherapy group compared with control group and 
chemotherapy group and NAC inhibited its expression completely while 
wortmannin increased it, which showed that ROS inhibited activation of 
Akt pathway and activated caspase pathway and Akt pathway was upstream 
of caspase pathway in thermo-chemotherapy. (C) Western blot analysis of 
phosphorylation of Akt and caspase-3 expression in cells following different 
treatment in A549 cells. *P<0.05 vs. control group; #P<0.05 vs. thermo-
chemotherapy group. Semi-quantitative analyses were performed from three 
independent experiments for t-Akt /β-actin.
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therapy was regarded as ‘green treatment’ by the clinicians 
(19). In 1990s, some investigators paid attention to the 
phenomenon of cell apoptosis induced by heat. This study 
shows that thermotherapy in combination with chemotherapy 
could increase injury of drugs on tumor cells by increasing 
ROS production, which leads to Akt activation, and apoptosis 
of A549 cells through caspase cascade, which was consistent 
with observation in vivo.
Normally, production and clearance of ROS is in a dynamic 
balance (20). Cell growth needs some ROS and ROS causes 
tissue cell apoptosis or necrosis (21). When ROS balance was 
broken, more ROS would be produced and oxidation stress 
occurred, which would induce internal Ca2+ flow, unregulating 
the expression of bax and activating caspase, then leading 
to cell apoptosis (22,23). ROS was induced in the process 
of tumor thermotherapy (24). The results of this study show 
that thermotherapy in combination with drugs would change 
induction and effect of ROS on tumor cells, which provides 
a new approach to treat tumors. This study finds that thermo-
therapy could increase production of intracellular ROS, which 
is an important factor of apoptosis. It is also found that this 
induction of ROS caused by thermotherapy could be inhibited 
by the ROS inhibitor NAC, but not by the PI3K inhibitor, 
wortmannin (Fig. 3). Therefore, ROS is likely to be upstream 
of inhibition on Akt pathyway activation.
PI3K (phosphoinositide 3 kinase) is a phosphatidyl kinase 
and induced tumor cell hyperplasia by activating apoptosis-
related Akt pathway (25). Its anti-apoptosis function may 
have related to caspase activation. Phosphorylation of Akt 
could resist apoptosis in chemotherapy and radiotherapy (26). 
Previous studies (27) have showed that phosphorylation of 
Akt was increased from normal cells to atypia then to malig-
nant transformation with molecular markers related to loss 
of apoptosis indicating that Akt extended survival of tumor 
cells and inhibited apoptosis. Noske et al (28) found that there 
was overexpression of Akt in 58% primary ovarian cancer 
and RNA interference inhibited phosphorylation of Akt to 
inhibit ovarian cancer cell proliferation. In this study, p-Akt is 
highly-expressed in A549 cells and heat can decrease levels of 
Akt phosphorylation. Also, p-Akt could be inhibited by NAC 
and wortmannin (Figs. 4 and 5). Results of MTT and FCM 
show that cell proliferation rates decreased and apoptosis 
rates increased in thermo-chemotherapy group. Therefore, 
inhibition of thermotherapy on lung tumor cell growth was 
associated with Akt pathway activation.
In practice, wortmannin could inhibit phosphorylation of 
Akt both in vivo and in vitro (29). In our study, levels of p-Akt 
in thermo-chemotherapy group were significantly lower than 
those in control group and chemotherapy group. Wortmannin 
completely inhibited phosphorylation of Akt (Figs. 4 and 5). 
Combined with results of MTT and FCM, cell apoptosis rates 
in wortmannin group are higher than those in thermo-chemo-
therapy group, which shows that thermotherapy inhibited 
Akt pathway activation and NAC activated the Akt pathway. 
Wortmannin can increase antitumor effects of thermotherapy 
at the same time.
Caspases are a group of cysteine proteases, which have 
similar amino acid sequences, and play an important role in 
cell apoptosis. Caspase family enzymes regulate cell apop-
tosis. Many apoptosis factors induce apoptosis by caspase-3 
mediated signal pathway (30). In this study, heat could 
induce caspase-3 activation in A549 cells and NAC could 
inhibit caspase-3 expression in heated A549 cells (Figs. 4 and 
5), which suggests that production of ROS was upstream of 
caspase-3 activation in A549 cell apoptosis induced by heat. 
When heat inhibited phosphorylation of Akt, the expression 
of caspase-3 increased, which shows that inhibition of Akt 
pathway activation was upstream of caspase-3 activation.
In summary, thermotherapy could block the cell cycle 
and improved induction of cell apoptosis (31). Cell apoptosis 
is one characteristic of cell life and an active death form 
conducted by genes. Inhibition of PI3K/Akt pathway activa-
tion could increase tumor cell apoptosis induced by drugs 
(32). Cell apoptosis rate in wortmannin group increased. But 
level of p-Akt increased while cell apoptosis rate decreases 
after NAC addition, which suggests that ROS inhibited acti-
vation of Akt pathway and induced cell apoptosis. Inhibition 
of caspase-3 activity or antagonism of its function may 
inhibit cell apoptosis, indicating that caspase-3 is essential 
to cell apoptosis (33). Thus, thermotherapy in combination 
Figure 5. Phosphorylation of Akt and caspase-3 expression in vivo. This 
figure was confirmed in vivo. (A) Phosphorylation of Akt in thermo-che-
motherapy group decreased significantly compared with control group and 
chemotherapy group. Wortmannin inhibited it thoroughly. (B) Compared 
with control group and chemotherapy group, caspase-3 expression increased 
in thermo-chemotherapy group. NAC could inhibit it completely and it 
increased in wortmannin group. (C) Western blotting analysis phosphoryla-
tion of Akt and caspase-3 expression in cells following different treatment 
in vivo. *P<0.05 vs. control group; #P<0.05 vs. thermo-chemotherapy group. 
Semi-quantitative analyses were performed from three independent experi-
ments for t-Akt /β-actin.
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with chemotherapy showed a stronger inhibitory effect than 
chemotherapy alone on A549 cell growth, probably through 
induction of ROS production and subsequent inhibition of 
Akt phosphorylation to activate caspase cascade, which would 
lead to lung cancer cell apoptosis. All results were confirmed 
in vivo. These results provide a theoretical basis for thermo-
therapy clinical practice.
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